When blood sugar starts to rise after a person eats, GLP-1 agonists cause the body to make more insulin. This extra insulin ...
Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...
GLP-1 receptor agonist therapy reduced surgical abscess repairs and hospitalizations among people with hidradenitis ...
GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...
Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...
There's mounting evidence that popular drugs prescribed for diabetes management and weight loss - better known by trade names ...
GLP‑1–pathway agonists such as semaglutide and newer multi‑agonists have transformed care for obesity and diabetes, yet ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...
Terns Pharmaceuticals halts its TERN-601 obesity program due to insufficient efficacy and safety concerns. Click here to read ...
CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC ...